MBRX vs SPY
Moleculin Biotech Inc (MBRX) versus SPDR S&P 500 ETF Trust (SPY) — a side-by-side from cached financials, not a winner call.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
SPY does not have a complete income-statement cache yet.
MBRX currently screens at market cap $8.2M. SPY currently screens at market cap $0.
Not investment advice. Open the MBRX and SPY stock pages for the full models.
Not investment advice.